SGLT2 Inhibitor
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study. (NCT04027530) | Amsterdam UMC, location VUmc | 2020-12-10 |
Track SGLT2 Inhibitor automatically
Every clearance here is in the API, with alerts when new ones post.